Scientific, Evidence-Based Cannabis Research Programs
From clinical trials to patient outcomes, Hytiva Research conducts cannabis research that empowers physicians, advances pharmaceuticals, and informs the patients who rely on cannabis for their health.
Hytiva Research Builds Clinical Evidence for Cannabis
Cannabis is one of the most widely used therapeutic substances in the world, yet clinical evidence still lags behind patient demand. We bridge this gap by conducting original research that provides physicians the data to prescribe with confidence, pharma teams the evidence to develop targeted treatments, and patients the science to make informed decisions about their care.
Hytiva Research has been collecting data for scientific research within the cannabis industry for over a decade. Hytiva's in-house Medical Doctors (MD), Compounding Pharmacists (PharmD) and others are continuously expanding our data, performing analyses, and designing clinical trials.
Hytiva Research Clinical Trials
In the 2026 year, we are releasing dates for clinical trials, for which individuals may join our growing list of potential candidates. Interested in becoming a clinical trial candidate? Register as a candidate to be considered for eligibility in limited-enrollment trials related to your conditions. Trials will be focused on the following areas:
-
Clinical Trial
Sleep
Developing cannabis treatments for sleep-related ailments such as insomnia, improving sleep quality, and identifying the optimal cannabis compounds and dosing strategies.
-
Clinical Trial
Chronic Pain
Demonstrate pain score reduction, opioid sparing, improved quality of life, and strong safety/tolerability via medical cannabis protocols for chronic pain.
-
Clinical Trial
Inflammation
Using low-psychoactive, balanced CBD:THC ratios to maximize efficacy via entourage effect while minimizing side effects pain relief, with terpenoid profiles optimized for anti-inflammatory/sedative effects.
-
Clinical Trial
PTSD / Anxiety
Exploring optimal cannabis medicinal products and doses to reduce the effects of PTSD and anxiety, and reducing dependency on high adverse-reaction prescriptions.
Recent Publications
Access our latest clinical findings, literature reviews, and original research reports.
-
Cannabis Therapeutics in Parkinson’s Disease -
Cannabis Use and Long-Term Cognitive Aging -
Cannabidiol Plus Vitamin D in Hepatocellular Carcinoma -
Cannabinoids and Cutaneous Malignancies -
Topical Cannabinoids in Inflammatory Dermatoses -
The Future of Cannabinoid Dermatology -
The Entourage Effect -
Cancer Care Evolution
Collaborate With Us
We partner with pharmaceutical companies, universities, hospitals, and research institutions to accelerate the future of medical cannabis. Whether you're launching a clinical trial or exploring a novel therapeutic application, our team provides the expertise and infrastructure to move your research forward.
Start a Conversation